A Systematic Review on Various Therapeutic Options for Coronavirus Outbreak

Author:

Khan Sharib Raza,Sharma Babita,Bhattacharya SankhaORCID

Abstract

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) or coronavirus disease that emerged in Wuhan, China's Hubei province. According to a Wuhan citizen, the virus spread from the Wuhan fish market to humans via a form of waterborne transmission. The WHO proclaimed the SARS-CoV-2 Pandemic a global public health emergency in March of the following year. Rather than influencing the individual animals mostly, the movement of humans and a few days later, the infection spread to other parts of the world by the distribution of specimens to animals and by the movement of humans, causing considerable illness in human populations. An estimated one and a total of nearly sixty-eight million two hundred and fifty-six million people have been impacted, including one and a million thousand five hundred and sixty thousand fatalities in more than two hundred countries around the world. As of the present, there are no medicines or vaccinations against the world's first SARS-CoV-2 virus are in clinical trials molecular and cellular studies of CoVs, as well as their care, were reviewed in this latest assessment. Keywords:  SARS-CoV-2, WHO, Global pandemic, Human coronaviruses, Pathogenesis, Treatments

Publisher

Society of Pharmaceutical Tecnocrats

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3